Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Retained Earnings (2020 - 2025)

Maravai Lifesciences Holdings has reported Retained Earnings over the past 6 years, most recently at $524000.0 for Q4 2025.

  • Quarterly results put Retained Earnings at $524000.0 for Q4 2025, down 99.63% from a year ago — trailing twelve months through Dec 2025 was $524000.0 (down 99.63% YoY), and the annual figure for FY2025 was $524000.0, down 99.63%.
  • Retained Earnings for Q4 2025 was $524000.0 at Maravai Lifesciences Holdings, down from $579000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for MRVI hit a ceiling of $404.8 million in Q4 2022 and a floor of $524000.0 in Q4 2025.
  • Median Retained Earnings over the past 5 years was $218.0 million (2021), compared with a mean of $213.4 million.
  • Biggest five-year swings in Retained Earnings: soared 419556.82% in 2021 and later crashed 99.65% in 2025.
  • Maravai Lifesciences Holdings' Retained Earnings stood at $184.6 million in 2021, then soared by 119.31% to $404.8 million in 2022, then decreased by 29.41% to $285.7 million in 2023, then tumbled by 50.69% to $140.9 million in 2024, then plummeted by 99.63% to $524000.0 in 2025.
  • The last three reported values for Retained Earnings were $524000.0 (Q4 2025), $579000.0 (Q3 2025), and $71.4 million (Q2 2025) per Business Quant data.